Pulmonary drug delivery system

International Journal of PharmTech Research

Volumn 4, Issue 1, 2012, Pages 293-305

  Karhale Ashish, A ^a   Chaudhari Hiralal, S ^a   Ughade Prajkta, L ^a   Baviskar Dheeraj, T ^a   Jain Dinesh, K ^b  

^a Institute of Pharmaceutical Education   (India)

^b IPS Academy   (India)

Author keywords

Apllications; Asthma; COPD; Inhalers; Lungs; Pulmonary

Indexed keywords

ACETYLCYSTEINE; AMPHOTERICIN; DORNASE ALFA; ERGOTAMINE; GENTAMICIN; GLYCERYL TRINITRATE; LOW MOLECULAR WEIGHT HEPARIN; NICOTINE; OPIATE; PENTAMIDINE; TOBRAMYCIN;

ACUTE LUNG INJURY; AEROSOL; ANGINA PECTORIS; ASTHMA; BONE DISEASE; BREATH HOLDING; BRONCHIOLE; BRONCHUS; BRONCHUS OBSTRUCTION; CANCER CHEMOTHERAPY; CELL CULTURE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CILIATED EPITHELIUM; CYSTIC FIBROSIS; DENSITY; DIABETES MELLITUS; DRUG BIOAVAILABILITY; DRUG DELIVERY SYSTEM; DRUG DIFFUSION; EMPHYSEMA; GENE THERAPY; INHALATIONAL DRUG ADMINISTRATION; INTRANASAL DRUG ADMINISTRATION; INTRATRACHEAL DRUG ADMINISTRATION; LUNG ALVEOLUS EPITHELIUM; LUNG STRUCTURE; MEDICAL NEBULIZER; METERED DOSE INHALER; MIGRAINE; MORPHOLOGY; NASOPHARYNX; PAIN; PARTICLE SIZE; POWDER INHALER; PULMONARY DRUG DELIVERY SYSTEM; PULMONARY HYPERTENSION; RESPIRATORY AIRFLOW; REVIEW; SEDIMENTATION; SMOKING CESSATION; TIDAL VOLUME; TRACHEOBRONCHIAL TREE; TRANSPLANTATION; TUBERCULOSIS; VACCINATION; VELOCITY; VENTILATOR;

EID: 84859937742     PISSN: None     EISSN: 09744304     Source Type: Journal    
DOI: None     Document Type: Review

References (30)

1. Michael T. Newhouse., Encyclopedia of Pharmaceutical Technology, Dekker. New York Informa Healthcare USA, 2000, 19, 1279-1285.
2. Derek I. D., & Jesse Z., Review on "dry powder platform for pulmonary drug delivery"., Particuology., 2008, 225-238.
3. Remington's Pharmaceutical science, vol-1., 1990, 18, 863-864.
4. Hickey A. J. Inhalation Aerosols., Physical and Biological Basis for Therapy, Marcel Dekker, New York., 1996, 3, 223-228.
5. Aulton M. E. Wells T. I., Pulmonary drug delivery; "Pharmaceutics the science of dosage form design"., Churchill Livingstone.,1998,2, 403-405.
6. Banker G. S. and Rhodes T. R., Modern Pharmaceutics, Marcel Dekker, 4, 529-586.
7. Cole R. B. & Mackay A. D., Concepts of pulmonary physiology., In Essentials of respiratory disease, New York, Churchill Livingstone, 1990, 3, 49-60.
8. David A. E. Abdelaziz B. and Robert L., "Recent advances in pulmonary drug delivery using large, porous inhaled particles, " J Appl Physiology 1998, 25, 379-385.
9. Tong H. H. Y. and Chow A. H. L., An article from School of Pharmacy, Chinese University of Hong Kong. 2002, 2, 125-129.
10. Chawla, A. Taylor, K. M. G. Newton, J. M. and Johnson M. C. R, "Production of spray-dried salbutamol sulphate for use in dry powder aerosol formulation", Int. J. Pharm., 1994, 108, 233-240.
11. Lin H. Li. Cho HJ. Air-liquid interface (ALI) culture of human bronchial epithelial cell monolayers as an in vitro model for airway drug transport studies. J Pharm Sci 2007, 96, 2, 341-350.
12. Blank F. Rothen-Rutishauser B. M. Schurch S., An optimized in vitro model of the respiratory tract wall to study particle cell interactions. J Aerosol Med 2006, 19, 3, 392-405.
13. Harrison Principles of Internal medicine, mc Grew, Hill medical publication 2003, 17, 1596-1636.
14. John S. P., "Market Trends in Pulmonary Therapies, " 2006, 2, 485-490.
15. David A. E. Andre X. V., Jonathan M., and Nicolas Tsapis Harvard University, Cambridge, Massachusetts, U. S., "Recent Advances Related to the Systemic Delivery of Therapeutic Molecules by Inhalation", modern pharmaceutics marcel Dekker 2004,1-10.
16. David R. O., Geremia B. B., Bernard Z., "Future options for insulin therapy, current science", 2002, 12, 1548-1554.
17. Gowthamarajan K. and Giriraj T. K., Oral Insulin-Fact or Fiction resonece-2003, 38-40.
18. Al-Tabakha, M. M. Alerid A. "challenges in insulin drug delivery system", Indian journal of pharmaceutical science, 2008,. 278-284.
19. Naryani R., "Oral delivery of insulin making needless", trends biometer. artifs. organ, 2011, 159, 10, 12-16.
20. Jaleh V., "Insulin Delivery Systems for Controlling Diabetes", Recent Patents on Endocrine, Metabolic & Immune Drug Discovery 2007, 1, 25-40.
21. Gabrielle P. A., Francis V. B. & Karim A., "Preparation and characterization of spray-dried tobramycin powders containing Nanoparticles for pulmonary delivery", International Journal of Pharmaceutics 2009, 365, 162-169.
22. Robyn J. & Barst, M. D., "Recent Advances in the Treatment of Pulmonary Artery Hypertension", Acc Current Journal Review November/December 1998, 61-63.
23. John S. P., "Market Trends in Pulmonary Therapies", inspiration, 2006, 1-10.
24. Montgomery A. B., "Aerosolized Pentamidine for Treatment and Prophylaxis of pneumocystis carinii Pneumonia in Patients with Acquired Immunodeficiency Syndrome", modern pharmaceutics Marcel Dekker 2004, 1-14.
25. Brain E., "pulmonary delivery of antitiritroviral drugs", dept. of microbiology, immunology, and seminar in paed infectious disese, 1996, 7,148-154.
26. Practical Aspects of Imaging Techniques Employed to Study Aerosol deposition and Clearance, modern pharmaceutics Marcel Dekker 2004, 38-43.
27. Pavan M. Chenchen W. and Anthony J. H., "Inhaled Drug Delivery for Tuberculosis Therapy", Pharmaceutical Research, 2009, 26, 11.
28. Tianzhi Y. Fatima M. & Shuhua B., "Pulmonary Delivery of Low Molecular Weight Heparins", Pharmaceutical Research, 2004, 19, 2009-2014.
29. John S. P., "Pulmonary delivery of drugs for bone disorders", Advanced Drug Delivery Reviews,2000, 42, 239-248.
30. Stephen J. F. and Babatunde A. O., "Pulmonary delivery of opioids as pain therapeutics", Advanced Drug Delivery Reviews 2006, 58, 1076-1088.